Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Readers worry that fraud may tarnish the field and slow the race for a cure. Also: Charles Blow’s farewell; treatment for ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Researchers found that white participants who frequently took sleep medications—meaning they used them five or more times a ...

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

A new study showed that people who took longer to enter this dream phase of sleep had higher levels of amyloid beta and tau, ...